Telomeres and telomerase: Implications for cancer and aging

Radiation Research

Volumn 155, Issue 1, 2001, Pages 188-193

  Shay, Jerry W ^a   Wright, Woodring E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ANIMAL; CELL AGING; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY; REVIEW; TELOMERE;

ANIMALS; CELL AGING; HUMANS; NEOPLASMS; TELOMERASE; TELOMERE;

EID: 0035219092     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/0033-7587(2001)155[0188:TATIFC]2.0.CO;2     Document Type: Article

References (59)

1. L. Hayflick, The limited in vitro lifetime of human diploid cell strains. Exp. Cell. Res. 37, 614-636 (1965).
2. H. Rubin, Cell aging in vivo and in vitro. Mech. Ageing Dev. 98, 1-35 (1997).
3. E. Bell, L. F. Marek, D. S. Levinstone, C. Merrill, S. Sher, I. T. Young and M. Eden, Loss of division potential in vitro: Aging or differentiation? Science 202, 1158-1163 (1978).
4. L. E. Orgel, The maintenance of the accuracy of protein synthesis and its relevance to ageing. Proc. Natl. Acad. Sci. USA 49, 517-521 (1963).
5. R. Holliday, L. I. Huschtscha, G. M. Tarrant and T. B. Kirkwood, Testing the commitment theory of cellular aging. Science 198, 366-372 (1977).
6. T. H. Norwood, W. R. Pendergrass, C. A. Sprague and G. M. Martin, Dominance of the senescent phenotype in heterokaryons between replicative and post-replicative human fibroblast-like cells. Proc. Natl. Acad. Sci. USA 71, 2231-2235 (1974).
7. R. M. Yanishevsky and G. H. Stein, Ongoing DNA synthesis continues in young human diploid cells (HDC) fused to senescent HDC, but entry into S phase is inhibited. Exp. Cell Res. 126, 469-472 (1980).
8. O. M. Pereira-Smith and J. R. Smith, Phenotype of low proliferative potential is dominant in hybrids of normal human fibroblasts. Somat. Cell Genet. 8, 731-742 (1982).
9. O. M. Pereira-Smith and J. R. Smith, Evidence for the recessive nature of cellular immortality. Science 221, 964-966 (1983).
10. C. L. Bunn and G. M. Tarrant, Limited lifespan in somatic cell hybrids and cybrids. Exp. Cell Res. 127, 385-396 (1980).
11. A. L. Muggleton-Harris and D. W. DeSimone, Replicative potentials of various fusion products between WI-38 and SV40 transformed WI-38 cells and their components. Somat. Cell Genet. 6, 689-698 (1980).
12. J. W. Shay, W. E. Wright and H. Werbin, Defining the molecular mechanism of human cell immortalization. Biochim. Biophys. Acta 1072, 1-7 (1991).
13. C. B. Harley, B. A. Futcher and C. W. Greider, Telomeres shorten during aging of human fibroblasts. Nature 345, 458-460 (1990).
14. N. D. Hastie, M. Dempster, M. G. Dunlop, A. M. Thompson, D. K. Green and R. C. Allshire, Telomere reduction in human colorectal carcinoma and with ageing. Nature 346, 866-868 (1990).
15. J. Lindsey, N. I. McGill, L. A. Lindsey, D. K. Green and H. J. Cooke, In vivo loss of telomeric repeats with age in humans. Mutat. Res. 256, 45-48 (1991).
16. T. DeLange, L. Shiue, R. M. Meyers, D. R. Cox, S. L. Naylor, A. M. Killery and H. E. Varmus, Structure and variability of human chromosome ends. Mol. Cell. Biol. 10, 518-527 (1990).
17. C. B. Harley, Telomere loss: Mitotic clock or genetic time bomb? Mutat. Res. 256, 271-282 (1991).
18. W. E. Wright and J. W. Shay, Telomere positional effects and the regulation of cellular senescence. Trends Genet. 8, 193-197 (1992).
19. J. W. Shay, Aging and cancer: Are telomeres and telomerase the connection? Mol. Med. Today 1, 378-384 (1995).
20. R. C. Allsopp, H. Vaziri, C. Patterson, S. Goldstein, E. V. Younglai, A. B. Futcher, C. W. Greider and C. B. Harley, Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. USA 89, 10114-10118 (1992).
21. W. E. Wright and J. W. Shay, The two-stage mechanism controlling cellular senescence and immortalization. Exp. Gerontol. 27, 383-389 (1993).
22. N-W. Kim, M. A. Piatyszek, K. R. Prowse, C. B. Harley, M. D. West, P. L. C. Ho, G. M. Coviello, W. E. Wright, S. L. Weinrich and J. W. Shay, Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2015 (1994).
23. W. E. Wright, D. Brasiskyte, M. A. Piatyszek and J. W. Shay, Experimental elongation of telomeres in immortal human cells extends the lifespan of immortal X normal cell hybrids. EMBO J. 15, 1734-1741 (1996).
24. A. G. Bodnar, M. Ouellete, M. Frolkis, S. E. Holt, C-P. Chiu, G. B. Morin, C. B. Harley, J. W. Shay, S. Lichtsteiner and W. E. Wright, Extension of lifespan by introduction of telomerase in normal human cells. Science 279, 349-352 (1998).
25. J. W. Shay, O. Peirera-Smith and W. E. Wright, A role for both Rb and p53 in the regulation of cellular senescence. Exp. Cell. Res. 196, 33-39 (1991).
26. E. Hara, H. Tsurai, A. Shinozaki, S. Nakada and K. Oda, Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of lifespan in human diploid fibroblasts, TIG-1. Biochem. Biophys. Res. Commun. 179, 528-534 (1991).
27. C. M. Counter, A. A. Avilion, C. E. LeFeuvre, N. G. Stewart, C. W. Greider, C. B. Harley and S. Bacchetti, Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11, 1921-1929 (1992).
28. J. W. Shay, W. E. Wright, D. Brasiskyte and B. A. Van Der Haegen, E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts. Oncogene 8, 1407-1413 (1993).
29. J. W. Shay and W. E. Wright, Quantitation of the frequency of immortalization of normal human diploid fibroblasts by SV40 large T-antigen. Exp. Cell. Res. 184, 109-118 (1989).
30. H. J. Cooke and B. A. Smith, Variability at the telomeres of the human X/Y pseudoautosomal region. Cold Spring Harbor Symp. Quant. Biol. 51, 213-219 (1986).
31. H. Vaziri, F. Schachter, I. Uchida, L. Wei, X. Zhu, R. Effros, D. Cohen and C. B. Harley, Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am. J. Hum. Genet. 52, 661-667 (1993).
32. J. D. Watson, Origin of concatameric T4 DNA. Nature 239, 197-201 (1972).
33. A. M. Olovnikov, Principles of marginotomy in template synthesis of polynucleotides. Doklady Akademii Nauk. SSSR 201, 1496-1499 (1971).
34. W. E. Wright, M. A. Piatyszek, W. E. Rainey, W. Byrd and J. W. Shay, Telomerase activity in human germline and embryonic tissues. Dev. Genet. 18, 173-179 (1996).
35. J. Feng, W. D. Funk, S. S. Wang, S. L. Weinrich, A. A. Avilion, C. P. Chiu, R. R. Adams, E. Chang, J. Yu and B. Villeponteau, The RNA component of human telomerase. Science 269, 1236-1241 (1995).
36. J. H. Zhu, H. Wang, J. M. Bishop and E. H. Blackburn, Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening. Proc. Natl. Acad. Sci. USA 96, 3723-3728 (1999).
37. C. M. Counter, W. C. Hahn, W. Wei, S. D. Caddie, R. L. Beijersbergen, P. M. Lansdorp, J. M. Sedivy and R. A. Weinberg, Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc. Natl. Acad. Sci. USA 95, 14723-14728 (1998).
38. T. L. Halvorsen, G. Leibowitz and F. Levine, Telomerase activity is sufficient to allow transformed cells to escape from crisis. Mol. Cell. Biol. 19, 1864-1870 (1999).
39. H. Vaziri and S. Benchimol, Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative lifespan. Curr. Biol. 8, 279-282 (1998).
40. S. Le, J. K. Moore, J. E. Haber and C. W. Greider, RAD50 and RAD51 define two pathways that collaborate to maintain telomeres in the absence of telomerase. Genetics 152, 143-152 (1999).
41. J. Wang, L. Y. Xie, S. Allan, S. D. Beach and G. J. Hannon, Myc activates telomerase. Genes Dev. 12, 1769-1774 (1998).
42. ink4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396, 84-88 (1998).
43. M. M. Ouellette, D. L. Aisner, I. Savre-Train, W. E. Wright and J. W. Shay, Telomerase activity does not always imply telomere maintenance. Biochem. Biophys. Res. Commun. 254, 795-803 (1999).
44. J. G. Rheinwald and H. Green, Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes. Nature 265, 421-424 (1977).
45. B. Vogelstein and K. W. Kinzler, The multistep nature of cancer. Trends Genet. 9, 138-141 (1993).
46. J. W. Shay and S. Bacchetti, A survey of telomerase in human cancer. Eur. J. Cancer 33, 787-791 (1997).
47. C. P. Morales, S. E. Holt, M. Ouellette, K. J. Kaur, Y. Yan, K. S. Wilson, M. A. White, W. E. Wright and J. W. Shay, Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat. Genet. 21, 115-118 (1999).
48. X-R. Jiang, G. Jimenez, E. Chang, M. Frolkis, B. Kuser, M. Sage, M. Beeche, A. G. Bodnar, G. M. Wahl and C. P. Chiu, Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat. Genet. 21, 111-114 (1999).
49. 1 checkpoint in telomerase-induced extended-lifespan human fibroblasts. Mol. Cell. Biol. 19, 2373-2379 (1999).
50. M. M. Ouellette, L. McDaniel, W. E. Wright, J. W. Shay and R. Shultz, The establishment of telomerase immortalized cell lines representing human chromosome instability syndromes. Hum. Mol. Genet. 9, 403-411 (2000).
51. W. C. Hahn, C. M. Counter, A. S. Lundberg, R. L. Beijersbergen, M. W. Brooks and R. A. Weinberg, Creation of human tumor cells with defined genetic elements Nature 291, 464-468 (1999).
52. D. Kipling, Mammalian telomerase: Catalytic subunit and knockout mice. Hum. Mol. Genet. 6, 1999-2000 (1997).
53. D. Kipling, Telomere structure and telomerase expression during mouse development and tumorigenesis. Eur. J. Cancer 33, 792-800 (1997).
54. M. A. Blasco, H. W. Lee, M. P. Hande, E. Samper, P. M. Lansdorp and R. A. DePinho, Telomere shortening and tumor formation by mouse cells lacking telomerase activity Cell 91, 25-34 (1997).
55. D. Wynford-Thomas and D. Kipling, Cancer and the knockout mouse. Nature 389, 551-552 (1997).
56. H-W. Lee, M. A. Blasco, G. J. Gottlieb, J. W. Horner, C. W. Greider and R. A. DePinho, Essential role of mouse telomerase in highly proliferative organs. Nature 39, 569-574 (1998).
57. K. L. Rudolph, S. Chang, H. W. Lee, M. Blasco, G. J. Gottlieb, C. Greider and R. A. DePinho, Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96, 701-712 (1999).
58. G. M. Coviello-McLaughlin and K. R. Prowse, Telomere length regulation during postnatal development and ageing in Mus spretus. Nucleic Acids Res. 25, 3051-3058 (1997).
59. B. S. Herbert, A. E. Pitts, S. I. Baker, S. E. Hamilton, W. E. Wright, J. W. Shay and D. R. Corey, Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proc. Natl. Acad. Sci. USA 96, 14276-14281 (1999).